Figure 3From: Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae Days to recovery from SIRS (<2 SIRS criteria or discharge).Back to article page